跳至主要内容
临床试验/NL-OMON50405
NL-OMON50405已完成不适用

Community-Acquired Pneumonia: lytA TArgeted real-time quantitative polymerase chaIN reaction for improved detection of pneumococci. - qPCR in community-acquired pneumonia, CAPTAI

oordwest Ziekenhuisgroep0 个研究点目标入组 980 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
980

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Age 18 years or above;
  • -Presentation at the emergency department (ED);
  • -Working diagnosis of CAP at the ED with the presence of at least two of the
  • following criteria:
  • 1. New or worsened coughing;
  • 2. Production of purulent sputum or change in sputum colour;
  • 3. Temperature >38.0 *C or <=36.0 *C (tympanic);
  • 4. Auscultatory findings consistent with pneumonia, including rales, evidence
  • of pulmonary consolidation (dullness on percussion, bronchial breath sounds,
  • or egophony), or both;
  • 5. White blood cell count of >10x10^9 cells/L or <4x10^9 cells/L or >15%
  • 6. C-reactive protein level >=30mg/L;
  • 7. Dyspnea, tachypnea, (>20 breaths per minute), or hypoxemia (arterial pO2
  • <60mmHg or peripheral O2 saturation <90%).
  • -New consolidation(s) on the chest radiograph or computed tomography (CT);
  • -No other explanation for the signs and symptoms;Control group 1 - Related
  • -Being aged 18 years or above;
  • -Close relative of the patient: relative defined as living in the same house as
  • the CAP patient or daily contact;
  • -Is at the hospital at the moment of inclusion of the CAP patient or is willing
  • to come for testing within 7 days.Control group 2 - Unrelated healthy
  • individuals
  • -Being aged 18 years or above;
  • -Subject with a preoperative appointment with the anaesthiologist for a planned
  • surgical procedure;
  • -Age, gender and time matched to an included CAP patient.Control group 3 -
  • Patients with stable COPD
  • -Being aged 18 years or above;
  • -Diagnosis of COPD confirmed with spirometry (GOLD criteria 2017)(76).Control
  • group 4 - Patients with exacerbation of COPD
  • -Being aged 18 years or above;
  • -Diagnosis of COPD confirmed with spirometry (GOLD criteria 2017)(76);
  • -Diagnosis of exacerbation of COPD: defined as an acute event characterised by
  • a worsening of the patient*s respiratory symptoms that is beyond normal
  • day-to-day variations and leads to a change in medication (76);

排除标准

  • In general:
  • -Pneumonia in the last month or pneumococcal pneumonia (proven by usual
  • diagnostics) in the last three months;
  • -Not capable of understanding information needed to sign informed
  • consent;Patients:
  • -Was included in the present study group before;
  • -Aspiration pneumonia;
  • -Hospitalisation for two or more days in the last 14 days;
  • -History of cystic fibrosis.For all control groups:
  • -Fits inclusion criteria for patient group;
  • -Present or recent hospitalisation (14 days);
  • -Use of antibiotics in the last 14 days, including maintenance antibiotic
  • therapy.Control group 1 and 2 - Related healthy controls and unrelated healthy
  • individuals
  • -Active infectious respiratory complaints defined as defined as two or more
  • respiratory symptoms (cough, nasal congestion, runny nose, sore throat or
  • -Temperature >38.0 *C
  • -Chronic pulmonary disease: COPD, asthma, cystic fibrosis, bronchiectasis;
  • Control group 3 - Patients with stable COPD
  • -Temperature >38.0 *C;
  • -Stable disease;
  • -Recent exacerbation (<1 month) defined as increased respiratory symptoms with
  • need of antibiotic and/or corticosteroid therapy.Control group 4 - Patients
  • with exacerbation of COPD
  • -Current pneumonia;
  • -Recent exacerbation (<1 month) defined as increased respiratory symptoms with
  • need of antibiotic and/or corticosteroid therapy.

研究者

发起方
oordwest Ziekenhuisgroep

相似试验